Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
T
TaiMed Biologics Inc
TPEX:4147
TaiMed Biologics Inc
TPEX:4147
Price:
61.2
TWD
-1.13%
Market Closed
Market Cap:
NT$16.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
TaiMed Biologics Inc
TPEX:4147
|
TW |
|
TNS energo Mari EI P.A.O.
MOEX:MISB
|
RU |
|
Thrace Plastics Holding and Commercial SA
LSE:0JAC
|
GR |
Wall St Price Targets
Price Forecast
Based on 5 analysts
Based on 5 analysts
+113% Upside
from
NT$61.2
today
TaiMed Biologics Inc (4147)’s 12-month stock price forecast through October 2027 has a consensus target of NT$130.56, implying 113% upside. The forecast is based on price targets from 5 Wall Street analysts.
TaiMed Biologics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TaiMed Biologics Inc's stock price target?
Price Target
130.56
TWD
130.56
TWD
According to Wall Street analysts, the average 1-year price target for TaiMed Biologics Inc is 130.56 TWD with a low forecast of 76.76 TWD and a high forecast of 189 TWD.
What is the Revenue forecast for TaiMed Biologics Inc?
Projected CAGR
7%
7%
The compound annual growth rate for Revenue over the next 2 years is 7%.
What is the Gross Profit forecast for TaiMed Biologics Inc?
Projected CAGR
19%
19%
The compound annual growth rate for Gross Profit over the next 2 years is 19%.